comparemela.com

Latest Breaking News On - Napproved drug products - Page 12 : comparemela.com

Sabal Therapeutics Announces Sales and Marketing Agreement to Promote Athena Bioscience Cardiovascular Product Portfolio

/PRNewswire/ Sabal therapeutics, LLC announced today that they have entered into an exclusive sales and marketing agreement with Athena Bioscience, LLC to.

FDA Cracks Down on Vaping Misinformation

In a consumer update, FDA warned consumers that certain wellness vaping products containing vitamins or essential oils are being sold illegally with unproven claims. Currently, FDA has not approved any vaping products to prevent or treat any health conditions or diseases.

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Acer Therapeutics and Relief Therapeutics Announce Issuance of U S Patent 11,154,521 Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation 26-Oct-2021

EQS-Adhoc: Acer Therapeutics and Relief Therapeutics Announce Issuance of U S Patent 11,154,521 Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation 26-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is so.

Amryt Pharma PLC advancing on multiple fronts

Amryt Pharma sells and develops orphan drugs used to treat rare diseases with two products on the market

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.